BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ambruzs JM, Larsen CP. Renal Manifestations of Inflammatory Bowel Disease. Rheum Dis Clin North Am 2018;44:699-714. [PMID: 30274631 DOI: 10.1016/j.rdc.2018.06.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang Z, Xu X, Dong Y, Zhang Y. The pathological and outcome characteristics of renal lesions in Crohn's disease. BMC Nephrol 2022;23:256. [PMID: 35850695 DOI: 10.1186/s12882-022-02883-8] [Reference Citation Analysis]
2 van Hoeve K, Hoffman I. Renal manifestations in inflammatory bowel disease: a systematic review. J Gastroenterol 2022. [PMID: 35834005 DOI: 10.1007/s00535-022-01903-6] [Reference Citation Analysis]
3 Qing JB, Song WZ, Li CQ, Li YF. The Diagnostic and Predictive Significance of Immune-Related Genes and Immune Characteristics in the Occurrence and Progression of IgA Nephropathy. J Immunol Res 2022;2022:9284204. [PMID: 35528619 DOI: 10.1155/2022/9284204] [Reference Citation Analysis]
4 Lei J, Xie Y, Sheng J, Song J. Intestinal microbiota dysbiosis in acute kidney injury: novel insights into mechanisms and promising therapeutic strategies. Ren Fail 2022;44:571-80. [PMID: 35350960 DOI: 10.1080/0886022X.2022.2056054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mohamed MMB, Flores-santiago J, Perincheri S, Velez JCQ. Granulomatous interstitial nephritis in a treatment-naïve patient with ulcerative colitis. Renal Failure 2022;44:525-8. [DOI: 10.1080/0886022x.2022.2053714] [Reference Citation Analysis]
6 Bernstein CN, Nugent Z, Shaffer S, Singh H, Marrie RA. Comorbidity before and after a diagnosis of inflammatory bowel disease. Aliment Pharmacol Ther 2021;54:637-51. [PMID: 34156724 DOI: 10.1111/apt.16444] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
7 Angeletti A, Arrigo S, Madeo A, Molteni M, Vietti E, Arcuri L, Coccia MC, Gandullia P, Ghiggeri GM. Different renal manifestations associated with very early onset pediatric inflammatory bowel disease: case report and review of literature. BMC Nephrol 2021;22:146. [PMID: 33888087 DOI: 10.1186/s12882-021-02358-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Adamkova P, Hradicka P, Gancarcikova S, Kassayova M, Ambro L, Bertkova I, Maronek M, Farkasova Iannaccone S, Demeckova V. Single Donor FMT Reverses Microbial/Immune Dysbiosis and Induces Clinical Remission in a Rat Model of Acute Colitis. Pathogens 2021;10:152. [PMID: 33540919 DOI: 10.3390/pathogens10020152] [Reference Citation Analysis]
9 Marotto D, Atzeni F, Ardizzone S, Monteleone G, Giorgi V, Sarzi-Puttini P. Extra-intestinal manifestations of inflammatory bowel diseases. Pharmacol Res 2020;161:105206. [PMID: 32998068 DOI: 10.1016/j.phrs.2020.105206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Tatiya-Aphiradee N, Chatuphonprasert W, Jarukamjorn K. Ethanolic Garcinia mangostana extract and α-mangostin improve dextran sulfate sodium-induced ulcerative colitis via the suppression of inflammatory and oxidative responses in ICR mice. J Ethnopharmacol 2021;265:113384. [PMID: 32927006 DOI: 10.1016/j.jep.2020.113384] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Chams S, Badran R, Sayegh SE, Chams N, Shams A, Hajj Hussein I. Inflammatory bowel disease: Looking beyond the tract. Int J Immunopathol Pharmacol 2019;33:2058738419866567. [PMID: 31382828 DOI: 10.1177/2058738419866567] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
12 Mutalib M. Renal involvement in paediatric inflammatory bowel disease. Pediatr Nephrol 2021;36:279-85. [PMID: 31820145 DOI: 10.1007/s00467-019-04413-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Romano C, Esposito S, Ferrara R, Cuomo G. Choosing the most appropriate biologic therapy for Crohn’s disease according to concomitant extra-intestinal manifestations, comorbidities, or physiologic conditions. Expert Opinion on Biological Therapy 2020;20:49-62. [DOI: 10.1080/14712598.2020.1689953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
14 Kim YN, Jung Y. [Renal and Urinary Manifestations of Inflammatory Bowel Disease]. Korean J Gastroenterol 2019;73:260-8. [PMID: 31132832 DOI: 10.4166/kjg.2019.73.5.260] [Reference Citation Analysis]
15 Garber A, Regueiro M. Extraintestinal Manifestations of Inflammatory Bowel Disease: Epidemiology, Etiopathogenesis, and Management. Curr Gastroenterol Rep. 2019;21:31. [PMID: 31098819 DOI: 10.1007/s11894-019-0698-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
16 Chang CJ, Wang PC, Huang TC, Taniguchi A. Change in Renal Glomerular Collagens and Glomerular Filtration Barrier-Related Proteins in a Dextran Sulfate Sodium-Induced Colitis Mouse Model. Int J Mol Sci 2019;20:E1458. [PMID: 30909435 DOI: 10.3390/ijms20061458] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]